Search

Search Constraints

You searched for: Author/Creator Xi, L

Search Results

3. 170PEcological diversity indices as measurements of tumor heterogeneity correlates with clinical outcomes in late stage small cell lung cancer (SCLC). (23rd October 2018)

4. 1426PLongitudinal plasma monitoring of subjects treated with EGFR-TKIs allows better understanding of evolution of acquired resistance and can inform optimal treatment strategies. (23rd October 2018)

5. 1373PIdentification of subjects with locally advanced lung cancer who are likely to respond to standard-of-care chemoradiotherapy by a longitudinal monitoring of circulating tumor DNA (ctDNA) using a comprehensive ultra-sensitive NGS assay. (23rd October 2018)

6. DOP72 Safety, tolerability and efficacy of anti-TL1A antibody PF-06480605 in treatment of ulcerative colitis: The open-label, multicentre, Phase 2a TUSCANY study. (15th January 2020)

7. P446 Transcriptional and microbial biomarkers of response to anti-TL1A therapy in ulcerative colitis: the Phase 2a TUSCANY study. (15th January 2020)

8. 125 Supplementing extra dietary DL-methionine mitigates effects of higher stocking density on growth performance, meat quality, and health status of broiler chicks. (5th December 2019)

9. DOP80 Integrated tissue transcriptomic and serum proteomic interrogation reveals biomarkers for endoscopic improvement and histologic remission after JAK3/TEC inhibition in Ulcerative Colitis (UC) (Phase 2b Vibrato study). (21st January 2022)